The 2019 MedChemComm Emerging Investigator Lectureship is now open for nominations.
Nominations will close 22 November 2018.
The recipient of the lectureship will receive a contribution of up to £1000 towards speaking at a conference in 2019.
Qualification
The lectureship is open to candidates who received their PhD in 2009 or later and who have made a significant contribution to medicinal chemistry in their early career, particularly if they have brought new ideas to drug discovery.
How you can nominate
If you would like to nominate someone please email us (medchemcomm-rsc@rsc.org) with the following details:
- Their name
- Their affiliation
- At least one paragraph explaining their achievements and why you think they should be considered
Additional supporting information, for example their CV, is very helpful in making a decision but is not mandatory for making a nomination.
Self-nominations are accepted but must be supported by a letter of support from your Head of Departments or similar person at your institute.
Selection
All qualified nominations will be considered and a short-list of candidates with be selected based on the information provided at nomination. The MedChemComm Editorial Board will then vote to select the recipient and the winner will be announced in late 2018.
Previous lectureship winners include:
- Dr. Gonçalo Bernardes (University of Cambridge, UK) – 2018
- Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
- Dr Alessio Ciulli (University of Dundee, UK) – 2016
- Professor Richard Payne (University of Sydney, Australia) – 2015
- Professor Christian Heinis (École Polytechnique Fédérale de Lausanne, Switzerland) – 2013
- Professor Patrick Gunning (University of Toronto, Canada) – 2012
